SCHEMBL9016370

SCHEMBL9016370

CS(=O)(=O)NC(=O)NCc1ccccc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.59
KDM4E B2RXH2 1/20 0.56
POLB P06746 1/20 0.56
TSHR P16473 1/20 0.56
RECQL P46063 1/20 0.56
CYP2C9 P11712 1/20 0.55
EPHX1 P07099 1/20 0.54
TP53 P04637 1/20 0.53
PTPN1 P18031 2/20 0.53
EPHX2 P34913 1/20 0.51
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA9 Q16790 1/20 0.51
FBP1 P09467 2/20 0.50
MAPT P10636 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
PPID Q08752 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6465923 0.81 SMN1; SMN2 (0.54) SMN1; SMN2CYP2C9EPHX1TP53PTPN1
SCHEMBL6466723 0.81 CYP2C9 (0.57) SMN1; SMN2TSHRCYP2C9EPHX1TP53
SCHEMBL714625 0.80 EPHX1 (0.77) SMN1; SMN2KDM4ETSHRCYP2C9EPHX1
SCHEMBL5186630 0.78 ALDH1A1 (0.75) SMN1; SMN2TSHRCYP2C9CA12CA1
SCHEMBL969258 0.77 SMN1; SMN2 (0.67) SMN1; SMN2TSHRCYP2C9EPHX1TP53
SCHEMBL6033584 0.77 TP53 (0.75) SMN1; SMN2KDM4ETSHRCYP2C9EPHX1
SCHEMBL5313231 0.76 KDM4E (0.61) KDM4EPOLBTSHRRECQLEPHX2
SCHEMBL11543125 0.76 TP53 (0.50) SMN1; SMN2KDM4EPOLBTSHRRECQL
SCHEMBL970225 0.76 SMN1; SMN2 (0.70) SMN1; SMN2POLBEPHX1TP53PTPN1
SCHEMBL26965437 0.75 KMT2A (0.68) KDM4EPOLBTSHRRECQLEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0748315-A1 USE OF IMIDAZOLE DERIVATIVES FOR TREATING DISORDERS INVOLVING ANGIOTENSIN RECEPTORS AT 1? AND AT 2?, CERTAIN SUCH PRODUCTS, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME ROUSSEL UCLAF (FR) 1996-12-18 EP disclosed